US10131667, Example 55;11-(2,6-difluoro-3,5-dimethoxyphenyl)-13-methyl-3-(1-methylpiperidin-4-yl)-4,5,7,11,13-pentazatricyclo[7.4.0.02,6]trideca-1(9),2,5,7-tetraen-12-one
Substituted tricyclic compounds as FGFR inhibitors
申请人:Incyte Corporation
公开号:US11053246B2
公开(公告)日:2021-07-06
The present invention relates to tricyclic compounds, and pharmaceutical compositions of the same, that are inhibitors of one or more FGFR enzymes and are useful in the treatment of FGFR-associated diseases such as cancer.